189 related articles for article (PubMed ID: 19561553)
1. Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography.
Shie P; Cardarelli R; Sprawls K; Fulda KG; Taur A
Nucl Med Commun; 2009 Sep; 30(9):742-8. PubMed ID: 19561553
[TBL] [Abstract][Full Text] [Related]
2. Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review.
Soelberg KK; Bonnema SJ; Brix TH; Hegedüs L
Thyroid; 2012 Sep; 22(9):918-25. PubMed ID: 22827552
[TBL] [Abstract][Full Text] [Related]
3. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K
Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
[TBL] [Abstract][Full Text] [Related]
4. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization.
Choi JY; Lee KS; Kim HJ; Shim YM; Kwon OJ; Park K; Baek CH; Chung JH; Lee KH; Kim BT
J Nucl Med; 2006 Apr; 47(4):609-15. PubMed ID: 16595494
[TBL] [Abstract][Full Text] [Related]
5. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma.
Kim TY; Kim WB; Ryu JS; Gong G; Hong SJ; Shong YK
Laryngoscope; 2005 Jun; 115(6):1074-8. PubMed ID: 15933524
[TBL] [Abstract][Full Text] [Related]
6. Focal Thyroid Incidentalomas on
de Leijer JF; Metman MJH; van der Hoorn A; Brouwers AH; Kruijff S; van Hemel BM; Links TP; Westerlaan HE
Front Endocrinol (Lausanne); 2021; 12():723394. PubMed ID: 34744999
[TBL] [Abstract][Full Text] [Related]
7. Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules.
Sebastianes FM; Cerci JJ; Zanoni PH; Soares J; Chibana LK; Tomimori EK; de Camargo RY; Izaki M; Giorgi MC; Eluf-Neto J; Meneghetti JC; Pereira MA
J Clin Endocrinol Metab; 2007 Nov; 92(11):4485-8. PubMed ID: 17684046
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of incidental thyroid nodules on 18F-fluorodeoxyglucose positron emission tomography imaging: are these significant?
Sharma SD; Jacques T; Smith S; Watters G
J Laryngol Otol; 2015 Jan; 129(1):53-6. PubMed ID: 25496842
[TBL] [Abstract][Full Text] [Related]
9. Incidental Thyroid Nodules at Non-FDG PET Nuclear Medicine Imaging: Evaluation of Prevalence and Malignancy Rate.
Yerubandi V; Chin BB; Sosa JA; Hoang JK
AJR Am J Roentgenol; 2016 Feb; 206(2):420-5. PubMed ID: 26797373
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of thyroid FDG uptake incidentally identified on FDG-PET/CT imaging.
Chen W; Parsons M; Torigian DA; Zhuang H; Alavi A
Nucl Med Commun; 2009 Mar; 30(3):240-4. PubMed ID: 19262287
[TBL] [Abstract][Full Text] [Related]
11. Significance of incidental focal fluorine-18 fluorodeoxyglucose uptake in colon/rectum, thyroid, and prostate: With a brief literature review.
Lee H; Hwang KH
World J Clin Cases; 2022 Dec; 10(34):12532-12542. PubMed ID: 36579086
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of thyroid incidentalomas identified by 18F-FDG PET/CT: correlation of ultrasonograpy findings with cytology results.
Demir Ö; Köse N; Özkan E; Ünlütürk U; Aras G; Erdoğan MF
Nucl Med Commun; 2016 Jul; 37(7):715-20. PubMed ID: 26963467
[TBL] [Abstract][Full Text] [Related]
13. Thyroid incidentalomas detected on 18F-fluorodeoxyglucose-positron emission tomography/computed tomography: Thyroid Imaging Reporting and Data System (TIRADS) in the diagnosis and management of patients.
Yoon JH; Cho A; Lee HS; Kim EK; Moon HJ; Kwak JY
Surgery; 2015 Nov; 158(5):1314-22. PubMed ID: 25958065
[TBL] [Abstract][Full Text] [Related]
14. Incidental thyroid lesions on FDG-PET/CT: a prevalence study and proposition of management.
Adas M; Adas G; Koc B; Ozulker F
Minerva Endocrinol; 2015 Sep; 40(3):169-75. PubMed ID: 26205646
[TBL] [Abstract][Full Text] [Related]
15. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT.
Bogsrud TV; Karantanis D; Nathan MA; Mullan BP; Wiseman GA; Collins DA; Kasperbauer JL; Strome SE; Reading CC; Hay ID; Lowe VJ
Nucl Med Commun; 2007 May; 28(5):373-81. PubMed ID: 17414887
[TBL] [Abstract][Full Text] [Related]
16. Focal uptake of (18)F-fluorodeoxyglucose by thyroid in patients with nonthyroidal head and neck cancers.
Nam SY; Roh JL; Kim JS; Lee JH; Choi SH; Kim SY
Clin Endocrinol (Oxf); 2007 Jul; 67(1):135-9. PubMed ID: 17465995
[TBL] [Abstract][Full Text] [Related]
17.
Ruhlmann M; Ruhlmann J; Görges R; Herrmann K; Antoch G; Keller HW; Ruhlmann V
Thyroid; 2017 Oct; 27(10):1300-1306. PubMed ID: 28793848
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of focal thyroid lesions incidentally detected in fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography images.
Yaylali O; Kirac FS; Yuksel D; Marangoz E
Indian J Cancer; 2014; 51(3):236-240. PubMed ID: 25494112
[TBL] [Abstract][Full Text] [Related]
19. The prevalence and clinical significance of (18) F-2-fluoro-2-deoxy-D-glucose (FDG) uptake in the thyroid gland on PET or PET-CT in patients with lymphoma.
Lin M; Wong C; Lin P; Shon IH; Cuganesan R; Som S
Hematol Oncol; 2011 Jun; 29(2):67-74. PubMed ID: 20635328
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography.
Salvatori M; Melis L; Castaldi P; Maussier ML; Rufini V; Perotti G; Rubello D
Biomed Pharmacother; 2007 Sep; 61(8):488-93. PubMed ID: 17604940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]